Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ammoxetine enteric-coated tablets in major depressive disorder
CTR20211677Phase 2Completed
- Sponsor
- Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ammoxetine in major depressive disorder (MDD), sponsored by Institute of Toxicology and Pharmacology, Academy of Military Medical Sciences, People's Liberation Army of China. Started Aug 2021; status: completed.
02
Drugs
ammoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20211677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211677.